Go to deals
Healthcare

NS PARTNERS CO., LTD. has been acquired by JMDC Inc.

Noritsu Koki Co., Ltd has sold NS PARTNERS CO., LTD. to JMDC Inc.

NS PARTNERS CO. is a Japanese company offering factoring services to healthcare providers.

JMDC is a Tokyo Stock Exchange (Mothers) listed company providing medical statistics data services, remote diagnostic image interpretation support services and sales of medical systems through a subsidiary called Doctor-NET Inc., and systems for drug stores Unike Software Research Co., Ltd.

Noritsu Koki Co. is a holding company (TSE 1st section-listed) whose subsidiaries engage in manufacturing and healthcare businesses, internationally.

Oaklins’ team in Japan acted as the sole financial advisor to Noritsu Koki Co., Ltd in this transaction.

Service
M&A sell-side
Parties

Talk to the deal team

 Taro  Okayama

Taro Okayama

Managing Director

Tokyo, Japan
Oaklins SXA
 Yasuhiro  Yasumuro

Yasuhiro Yasumuro

Director

Tokyo, Japan
Oaklins SXA
 Tszying  Chau

Tszying Chau

Analyst

Tokyo, Japan
Oaklins SXA

Related deals

Groupe Nature acquires Winco
Consumer & Retail | Healthcare

Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Learn more
Camelia pharmacy chain has been acquired by Medigate Management UAB
Consumer & Retail | Healthcare

Camelia pharmacy chain has been acquired by Medigate Management UAB

CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.

Learn more
Shield Therapeutics has raised funds
Healthcare

Shield Therapeutics has raised funds

Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.

Learn more